Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,418 followers.

RT @Osteoporosis_NL: Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis.…

19 Jul 2022

Reply Repost Favourite

RT @Osteoporosis_NL: Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis.…

15 Jul 2022

Reply Repost Favourite

Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis. Lloyd Tanner et al. Front Pharmacol 2022 Jun 2 https://t.co/Gf5OfPPx1K …nice in vitro and in vivo experiments …argument for clinical tri

15 Jul 2022

Reply Repost Favourite

RT @FrontPharmacol: New Research: Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmon…

06 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.